Helix BioMedix, Inc. (Helix) is specialty dermatology and consumer products skin health company. The Company is developing bioactive peptides for uses across a range of markets. The Company has developed a library containing an array of bioactive peptides based upon the diversity of structure, origin and activity of the class of innate immunity element. The Company has six classes of peptides, containing more than 100,000 peptide sequences. The Company's drug discovery and development programs focus on its lead candidates in the areas of anti-infective, anti-fungal and anti-inflammatory peptides based on the innate immune system. The Company has an initial focus on peptides for the treatment of acne and Methicillin-resistant Staphylococcus aureus (MRSA). The Company's lead lipohexapeptides include HB1345 and HB1275. The Company's cosmeceuticals include Apothederm skin care science.